Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/2000
06/15/2000WO2000034505A1 Expression system for factor viii
06/15/2000WO2000034499A1 Use of an immuno complex for the preparation of a therapeutic composition useful for transfecting a polynucleotide into macropinocyte cells
06/15/2000WO2000034498A1 Two-step immunization procedure against chlamydia infection
06/15/2000WO2000034496A2 Use of trans-activation and cis-activation to modulate the persistence of expression of a transgene
06/15/2000WO2000034494A1 A recombinant vector expressing multiple costimulatory molecules and uses thereof
06/15/2000WO2000034487A1 STREPTOCOCCAL C5a PEPTIDASE VACCINE
06/15/2000WO2000034485A2 Beta-1,3-galactosyltransferase homologs
06/15/2000WO2000034483A2 Compounds and methods for treatment and diagnosis of chlamydial infection
06/15/2000WO2000034481A2 DRUG TARGETS IN $i(CANDIDA ALBICANS)
06/15/2000WO2000034478A1 Betacellulin modification
06/15/2000WO2000034477A2 Neuron-associated proteins
06/15/2000WO2000034475A2 Grnf4, a gdnf-related neurotrophic factor
06/15/2000WO2000034474A2 Growth factor homolog zvegf3
06/15/2000WO2000034472A1 Spermatogenesis protein
06/15/2000WO2000034470A1 Npcbac06: human transitional endoplasmic reticulum atpase gene
06/15/2000WO2000034469A1 Compositions and methods for altering cell migration
06/15/2000WO2000034468A2 Muc-1 antagonists and methods of treating immune disorders
06/15/2000WO2000034467A1 Cancer cell vaccine
06/15/2000WO2000034465A2 HEAT SHOCK GENES AND PROTEINS FROM NEISSERIA MENINGITIDIS, CANDIDA GLABRATA AND $i(ASPERGILLUS FUMIGATUS)
06/15/2000WO2000034455A2 Methods and systems useful for transferring genes into pancreatic islets ex vivo and into the pancreas in vivo
06/15/2000WO2000034451A1 Treatment of pompe's disease
06/15/2000WO2000034447A2 Human ubiquitin ligase e3 for the modulation of nf-kappa b
06/15/2000WO2000034441A1 CONVERSION OF LAMININ 5 TO A MIGRATORY SUBSTRATE BY PROTEOLYSIS OF THE η2 CHAIN THEREOF
06/15/2000WO2000034332A1 Glp-1 analogues
06/15/2000WO2000034331A2 Analogues of glp-1
06/15/2000WO2000034330A1 Cark protein and nucleic acid molecules and uses therefor
06/15/2000WO2000034328A1 Tpaaoh04: human g protein sara gene
06/15/2000WO2000034317A2 Method for reducing immunogenicity of proteins
06/15/2000WO2000034315A2 Purification of echinocandin cyclopeptide compounds
06/15/2000WO2000034314A1 Pharmaceutical compositions comprising quinapril magnesium
06/15/2000WO2000034313A1 Procollagen c-proteinase inhibitors
06/15/2000WO2000034310A1 Purified and isolated serine-threonine kinase receptors associated protein
06/15/2000WO2000034309A1 Cloning and characterization of a cd2 binding protein (cd2bp2)
06/15/2000WO2000034308A2 Protein transduction system and methods of use thereof
06/15/2000WO2000034303A1 METHODS OF MODULATING TUMOR NECROSIS FACTOR α-INDUCED EXPRESSION OF CELL ADHESION MOLECULES
06/15/2000WO2000034302A1 Antisense modulation of egr-1 expression
06/15/2000WO2000034301A1 Antisense modulation of g-alpha-11 expression
06/15/2000WO2000034294A2 Tumor necrosis factor receptor homologue-1 ('trh1')
06/15/2000WO2000034236A1 REVERSIBLE AQUEOUS pH SENSITIVE LIPIDIZING REAGENTS, COMPOSITIONS AND METHODS OF USE
06/15/2000WO2000033917A1 Agents provided for treating tumors, based on liposomes, and containing tamoxifen
06/15/2000WO2000033894A1 Collagen hemostatic foam
06/15/2000WO2000033893A1 Sterile complex of therapeutic peptide bond to a polysaccharide
06/15/2000WO2000033889A1 Antisense modulation of g-alpha-13 expression
06/15/2000WO2000033872A2 Method of and compositions for immunization with the pseudomonas v antigen
06/15/2000WO2000033869A2 Use of human prostrate cell lines in cancer treatment
06/15/2000WO2000033868A1 Heparin cofactor ii-containing compositions and process for producing the same
06/15/2000WO2000033867A1 Method of treating thrombocytopenic purpura and hemolytic uremic syndrome
06/15/2000WO2000033866A1 Pharmaceutical compositions containing insulin
06/15/2000WO2000033865A1 Methods of inhibiting ectopic calcification
06/15/2000WO2000033864A1 Remedies for tactile failures
06/15/2000WO2000033863A2 Therapeutic agent for the suppression of snoring noises
06/15/2000WO2000033862A1 Self-emulsifying compositions for drugs poorly soluble in water
06/15/2000WO2000033861A2 Pharmaceutical compositions containing protein-disulfide isomerases
06/15/2000WO2000033858A1 Cancer treatment composition and method using natural plant essential oils with signal transduction modulators
06/15/2000WO2000033857A1 Cancer treatment composition and method using natural plant essential oils
06/15/2000WO2000033856A1 Cancer treatment composition and method using signal transduction modulators and natural plant essential oils
06/15/2000WO2000033817A1 Phospholipid compositions
06/15/2000WO2000033814A2 Method for administering agents to the central nervous system
06/15/2000WO2000033813A1 Administration of neurotrophic agents to the central nervous system
06/15/2000WO2000033810A1 Use of vitamin b12 in a nasal composition for delivering active agents to the central nervous system
06/15/2000WO2000033809A1 Compositions containing a peptide and polylactic-glycolic acid suitable for preparing subcutaneous implants with an extended release period
06/15/2000WO2000033658A1 Composition and method for regulation of body weight and associated conditions
06/15/2000WO2000023618A8 Polymorphism in a tgf-beta gene correlated to osteoporosis
06/15/2000WO2000015649A9 METHODS OF INHIBITING SMOOTH MUSCLE CELL PROLIFERATION AND PREVENTING RESTENOSIS WITH A VECTOR EXPRESSING RB2/p130
06/15/2000WO2000012678A3 Staphylococcus aureus genes and polypeptides
06/15/2000WO2000012547A3 Benzodiazepines and benzothiazepines derivatives and hbsag peptides binding to annexins, their compositions and use
06/15/2000WO2000011151A3 Direct oviduct transgenesis
06/15/2000WO2000011023A3 Ring modified cyclic peptide analogs
06/15/2000WO2000010600A3 Activation and protection of t-cells (cd4+ and cd8+) using an h¿2? receptor agonist and other t-cell activating agents
06/15/2000WO2000010598A3 Recombinant botulinium toxin for the treatment of mucus hypersecretion
06/15/2000WO2000009711A3 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE α1/β1 (hsGCα1/β1)
06/15/2000WO2000009693A3 Identification of the gene causing the mouse scurfy phenotype and its human ortholog
06/15/2000WO2000008143A3 Gene isolated on the short arm of human chromosome 17
06/15/2000WO2000006732A9 Polynucleotide encoding an autoantigen associated with endometriosis
06/15/2000WO2000006604A3 Use of cd25 binding molecules in the treatment of rheumatoid arthritis or skin diseases
06/15/2000WO2000005374A3 Molecules associated with cell proliferation
06/15/2000WO2000005369A3 Nucleotide sequences and amino acid sequences of secreted proteins involved in angiogenesis
06/15/2000WO2000005254A3 Novel peptides for use in immunotherapy of autoimmune diseases
06/15/2000WO2000005253A3 Antagonists specific for the corticotropin-releasing factor receptor type 2 (crfr2)
06/15/2000WO2000003018A3 Antibiotic protein and method of production
06/15/2000WO2000001821A3 Neurotransmission associated proteins
06/15/2000WO1999066051A3 Nek-related and bub1-related protein kinases
06/15/2000WO1999062940A3 Methods of altering cardiac cell phenotype
06/15/2000WO1999061452A3 acpS
06/15/2000WO1999060021A3 Use of activated t cells, nervous system-specific antigens for treating disorders of the nevrous system
06/15/2000WO1999059614A9 Modulation of angiogenesis and wound healing
06/15/2000WO1999058098A3 HUMAN ANTITHROMBIN IIIs AND METHODS RELATED THERETO
06/15/2000WO1999055858A3 Human nucleic acid sequences obtained from pancreas tumor tissue
06/15/2000WO1999055847A3 Enzymatic nucleic acids molecules which modulate the expressions and/or replication of hepatitis c virus
06/15/2000WO1999047669A3 Human nucleic acid sequences from tissue of breast tumors
06/15/2000WO1999014328A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/15/2000DE19857609A1 Verwendung von Erythropoietin zur Behandlung von cerebralen Ischämien des Menschen Use of erythropoietin for the treatment of cerebral ischaemias of the human
06/15/2000DE19856897A1 Therapeutikum zur Unterdrückung von Schnarchgeräuschen A therapeutic agent for suppressing snoring noises
06/15/2000CA2778047A1 Analogues of glp-1
06/15/2000CA2768016A1 Glp-1 analogues
06/15/2000CA2746535A1 Compounds and methods for treatment and diagnosis of chlamydial infection
06/15/2000CA2678259A1 A recombinant vector expressing multiple costimulatory molecules and uses thereof
06/15/2000CA2354644A1 Muc-1 antagonists and methods of treating immune disorders
06/15/2000CA2354612A1 Tumor necrosis factor receptor homologue-1 ("trh1")
06/15/2000CA2354233A1 Self-emulsifying compositions for drugs poorly soluble in water
1 ... 2380 2381 2382 2383 2384 2385 2386 2387 2388 2389 2390 2391 2392 2393 2394 2395 2396 2397 2398 2399 2400 ... 3163